Budget Impact Analysis of Rapid Screening for Staphylococcus aureus Colonization Among Patients Undergoing Elective Surgery in US Hospitals
- 2 January 2008
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 29 (1) , 16-24
- https://doi.org/10.1086/524327
Abstract
Objective. To evaluate the economic impact of performing rapid testing for Staphylococcus aureus colonization before admission for all inpatients who are scheduled to undergo elective surgery and providing subsequent decolonization therapy for those patients found to be colonized with S. aureus. Methods. A budget impact model that used probabilistic sensitivity analysis to account for the uncertainties in the input variables was developed. Primary input variables included the marginal effect of S. aureus infection on patient outcomes among patients who underwent elective surgery, patient demographic characteristics, the prevalence of nasal carriage of S. aureus, the sensitivity and specificity of the rapid diagnostic test for S. aureus colonization, the efficacy of decolonization therapy for nasal carriage of S. aureus, and cost data. Data sources for the input variables included the 2003 Nationwide Inpatient Sample data and the published literature. Results. In 2003, there were an estimated 7,181,484 patients admitted to US hospitals for elective surgery. Our analysis indicated preadmission testing and subsequent decolonization therapy for patients colonized with S. aureus would have produced a mean annual cost savings to US hospitals of $231,538,400 (95% confidence interval [CI], -$300 million to $1.3 billion). The mean annual number of hospital-days that could have been eliminated was estimated at 364,919 days (95% CI, 67,893-926,983 days), and a mean of 935 in-hospital deaths (95% CI, 88-3,691) could have been avoided per year. Sensitivity analysis indicated a 64.5% probability that there would be cost savings to US hospitals as a result of preadmission testing and subsequent decolonization therapy. Conclusion. The addition of preadmission testing and decolonization therapy to standard care would result in significant cost savings, even after accounting for variations in the model input values.Keywords
This publication has 37 references indexed in Scilit:
- Prevalence ofStaphylococcus aureusNasal Colonization in the United States, 2001–2002The Journal of Infectious Diseases, 2006
- The role of nasal carriage in Staphylococcus aureus infectionsThe Lancet Infectious Diseases, 2005
- The Burden of Staphylococcus aureus Infections on Hospitals in the United StatesArchives of internal medicine (1960), 2005
- Mupirocin Prophylaxis against Nosocomial Staphylococcus aureus Infections in Nonsurgical PatientsAnnals of Internal Medicine, 2004
- Nasal carriage of Staphylococcus aureus on admission to intensive care: incidence and prognostic significanceIntensive Care Medicine, 2003
- Elimination of Nasal Carriage of Staphylococcus aureus in Hemodialysis PatientsInfection Control & Hospital Epidemiology, 1996
- Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: A decision analysisAmerican Journal of Kidney Diseases, 1996
- Staphylococcus aureusNasal Carriage and Infection in Patients on HemodialysisNew England Journal of Medicine, 1986
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)—a controlled trialJournal of Antimicrobial Chemotherapy, 1986
- Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1984